Photo of Charissa Chang

Charissa Chang

  • ASSISTANT PROFESSOR Medicine, Liver Diseases
Print ProfilePrint Profile


  • Transplant Hepatology

  • Gastroenterology


  • American Board of Internal Medicine


  • MD, University of Maryland

  • Residency, Internal Medicine
    Boston University Medical Center

  • Fellowship, Gastroenterology
    University of Virginia Health System

  • Fellowship, Hepatology
    Mount Sinai Hospital


  • 2005 -
    Advanced Hepatology Fellowship Grant
    American Association of Liver Diseases

  • 1994 -
    Tau Beta Pi
    Johns Hopkins University

  • 1994 -
    Research and Excellence Provost's Award for Undergraduate
    Johns Hopkins University, Baltimore, Maryland

  • 1991 -
    Westinghouse Science Talent Search Semifinalist



  • Portal Hypertension
  • Treatment of Viral Hepatits
  • Fatty Liver, NASH


Chang CY, Hernandez-Prera JC, Roayaie S, Schwartz M, Thung SN. Changing epidemiology of hepatocellular adenoma in the United States: review of the literature. International journal of hepatology 2013; 2013.

Martin P, Chang C. Update on the United States Hepatitis B Treatment Algorithm. Current Hepatitis Reports 2007;.

Chang C, Singal A, Emre S, Schiano T, Lookstein R, Ganeshan S. Successful Use of Splenic Artery Embolization to Relieve Tense Ascites Following Liver Transplantation in a Patient with Budd Chiari Syndrome, Paroxysmal Nocturnal Hemoglobinuria, and Portal Vein Thrombosis: A Case Report. Liver Transplantation 2007; 13(11): 1532-1537.

Tuyama AC, Chang CY. Non-alcoholic fatty liver disease. Journal of diabetes 2012 Sep; 4(3).

Chang CY, Martin P, Fotiadu A, Hytiroglou P. A patient with chronic hepatitis B and regression of fibrosis during treatment. Seminars in liver disease 2010 Aug; 30(3).

Schiano T, Chang C. Drug Hepatototoxicity Update. Alimentary Pharmacology and Therapeutics 2007; 25(10): 1135-1151.

Ward SC, Chang CY, Peng L, Liu LU. Patient with hepatitis B and alcoholic liver disease before and after liver transplantation. Seminars in liver disease 2009 May; 29(2).

Caldwell S, Macik G, Chang C. Recombinant Activated Factor VII (rFVIIa) as a Hemostatic Agent in Liver Disease: A Break from Convention in Need of Controlled Trials. Hepatology 2004; 39(3): 592-598.

Tan HH, Chang CY, Martin P. Acetaminophen hepatotoxicity: current management. The Mount Sinai journal of medicine, New York 2009 Feb; 76(1).

Caldwell S, Krugner-Higby L, Nakamoto R, Chang C. The Mitochondria in Non-Alcoholic Fatty Liver Disease. Clinics in Liver Disease 2004; 8(3): 595-617.

Chang C, Argo C, Caldwell S, Al-Osaimi A. Antioxidant Therapy in Non-Alcoholic Fatty Liver Disease. J Clin Gastroenterol 2005; 39(suppl 4).

Caldwell S, Chang C, Nakamoto R, Krugner-Higby L. Enlarged hepatocytes in NAFLD examined with osmium fixation: does microsteatosis underlie cellular ballooning in NASH?. Clinics in Liver Disease 2004; 8(3): 595-617.

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Below are financial relationships with industry reported by Dr. Chang during 2015 and/or 2016. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.


  • Gilead Sciences, Inc.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Icahn (East) Building Floor 4th
1425 Madison Avenue
New York, NY 10029

Tel: 212-241-0034
RMTI - Liver Disease Practice

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-241-0034
Fax: 212-289-7738
Get Directions
Insurance Plans
  • Aetna
  • Beech Street
  • Best Doctor
  • Choice Care
  • Cigna - HMO
  • Group Health Insurance, Inc.
  • Health Insurance Plan (HIP)
  • HealthNet
  • HealthPlus, Inc.
  • Island Group
  • Magnacare
  • Medicaid
  • Medicare
  • MetroPlus Health Plan
  • MultiPlan, Inc.
  • Neighborhood Health Providers, LLC
  • Private Healthcare Systems (PHCS)
  • Travel Care Services
  • United Healthcare
  • United Healthcare Empire Plan
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Personal Check
  • Cash

RMTI - Liver Transplant Practice

5 East 98th Street
12th Floor
New York, NY 10029

Tel: 212-241-8035
Get Directions

RMTI - Chinatown Satellite

168 Centre Street, Suite 3 M
New York, NY 10013

Tel: 212-731-3610
Get Directions